tility of side-by-side and simultaneous bilateral placement of metal stent for hilar biliary obstructio
Not Applicable
Not yet recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0003617
- Lead Sponsor
- Inha University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
? Histologic confirmed unresectable hilar cholangiocarcinoma or clinically suspicious unresectable hilar cholangiocarcinoma
? Bismuth type II or more degree of bismuth types (II, III, IV)
? predictive suvival period is more than 3 month
Exclusion Criteria
? Not suitable for endoscopic retrograde pancreaticocholedochoscopy
?Over 3 months after endoscopic retrograde pancreaticocholedochoscopy, endoscopic sphincterotomy, or endoscopic retrograde bile duct drainage / endoscopic transnasal bile duct drainage
? uncontrolled blood clotting disorder
? Patients with poor performance status
? Papillary type tumor in the bile duct (Intraductal papillary mucinous neoplasm- bile duct)
? pregnant or lactating status
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The stent patent period
- Secondary Outcome Measures
Name Time Method The survival period;the technical succsess of metal stent insertion;stents alignment;The clinical success of stent;Early adverse events related to stent insertion;motality related to procedure;Late adverse events related to stent insertion;The reason for stent malfunction;The way for the treatment of stent malfunction